Roflumilast : A New Anti-inflammatory Drug For COPD Patients
Unlike the many routine anti-inflammatory drugs that are currently being used to treat COPD, this study in The Netherlands involved use of a new drug named Roflumilast which targets the enzyme that is specifically involved in bronchospasm. Many COPD patients experience severe breathing difficulties when they develop bronchospasm -the sudden inflammation and narrowing of the airways. Roflumilast seems to help reduce inflammation in the airways.
Read More